Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates
about
Experimental primates and non-human primate (NHP) models of human diseases in China: current status and progressCross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primatesEmergence and pandemic potential of swine-origin H1N1 influenza virusThe Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment.African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014.Correlation between Virus Replication and Antibody Responses in Macaques following Infection with Pandemic Influenza A Virus.Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys.Animal models for the preclinical evaluation of candidate influenza vaccines.The innate immunity of guinea pigs against highly pathogenic avian influenza virus infectionA reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains.New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination.A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection.Cross-protective immune responses elicited by live attenuated influenza vaccinesH5N1 pathogenesis studies in mammalian models.Dogs are highly susceptible to H5N1 avian influenza virus.Animal Models for Influenza Virus Pathogenesis and Transmission.Animal models for influenza viruses: implications for universal vaccine developmentExperimental infection of macaques with a wild water bird-derived highly pathogenic avian influenza virus (H5N1).Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity.A live attenuated vaccine prevents replication and transmission of H7N9 virus in mammals.Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaqueDevelopment of live-attenuated influenza vaccines against outbreaks of H5N1 influenza.Generation and protective efficacy of a cold-adapted attenuated avian H9N2 influenza vaccine.Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine.Principles underlying rational design of live attenuated influenza vaccines.Evaluation of Macaca radiata as a non-human primate model of Dengue virus infection.Noninvasive vaccination against infectious diseases.The Marmoset as an Animal Model of Influenza: Infection With A(H1N1)pdm09 and Highly Pathogenic A(H5N1) Viruses via the Conventional or Tracheal Spray Route.A live attenuated vaccine prevents replication and transmission of H7N9 highly pathogenic influenza viruses in mammals
P2860
Q26860345-69715EE7-4155-42C4-A001-7430F5540E1EQ27348520-73D4F57E-015A-45FE-A768-9E4452090F79Q29619003-26C87849-5483-4BFB-8A41-42B5C4DF6BC2Q30205724-40C89B4D-4F22-4975-BB98-BDD53BB113C8Q30362332-A5E9072E-9477-44C1-A8BC-FAC48E4B92D9Q30372479-1243D096-E893-4A6E-B282-64B3F5CE11ADQ30381056-703578B1-B999-4D1D-9C0C-4515854DAFC6Q30382650-1EDB7B29-59CD-40F9-9499-4FFA6C8D776DQ30383623-343F0B7D-37E5-4013-9DE9-6CBF38A7E7D5Q30401156-7C5EAEAC-0B58-4FF1-8825-D67DD58B647AQ30402334-C1F7AE8E-990A-472A-A26D-BB6B5C98E56CQ30407424-4C65A625-96AC-4226-8CFC-EC0112DBE06EQ30412222-6BB7AE29-4D01-4818-BB28-4FE69DA2E48CQ30414652-F8AFA013-6CE3-4E23-AFA8-5F8E93D84EE3Q30426540-79987DE0-E7FF-49A6-9DFF-E2AC567EECAFQ30427806-7B99C0DE-5502-4A8A-B048-3A42BD8C33D9Q34037274-6A0BE221-3830-466A-8A1E-274A9743779BQ34714853-730A634D-6ACD-47C0-ABF5-298B4B49412EQ34809686-604D3FD4-7372-4578-9DCA-1FB90989E1F6Q35075577-2B4AEF6F-F7F8-404F-B476-FECA2381BC39Q35151690-2C0C44A2-9F95-4AF8-B797-C26A628AB78DQ35710438-759F5669-ADA7-4879-AB36-5B2FAEAB7C03Q36023157-FB93DD82-EAFE-423D-8636-37D1AE082FA7Q36482772-FC82A2E6-D08B-47D0-A762-27C391525084Q37125370-271BD102-3619-489F-B8E1-1B0D5D36D5E3Q38627438-50C44F69-7B37-4D2D-B9EB-B51862523098Q39770895-8C2060A7-0107-44D6-AFF7-7FD446996BB9Q50299354-C5690C12-130F-4EB5-908F-DFE51CEDD108Q52602778-F3F01FE7-44C6-45BE-A65B-49D7C01CD788Q55155382-0BC70EC1-8E1C-4AFE-8A84-BC47384BE9EBQ56971807-03A9BC58-A867-4DB2-BD95-EB358B43B1F4
P2860
Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Immunogenicity and protective ...... 1 vaccine in nonhuman primates
@ast
Immunogenicity and protective ...... 1 vaccine in nonhuman primates
@en
Immunogenicity and protective ...... 1 vaccine in nonhuman primates
@nl
type
label
Immunogenicity and protective ...... 1 vaccine in nonhuman primates
@ast
Immunogenicity and protective ...... 1 vaccine in nonhuman primates
@en
Immunogenicity and protective ...... 1 vaccine in nonhuman primates
@nl
prefLabel
Immunogenicity and protective ...... 1 vaccine in nonhuman primates
@ast
Immunogenicity and protective ...... 1 vaccine in nonhuman primates
@en
Immunogenicity and protective ...... 1 vaccine in nonhuman primates
@nl
P2093
P2860
P3181
P1433
P1476
Immunogenicity and protective ...... 1 vaccine in nonhuman primates
@en
P2093
Chris Kafai Li
Gongxun Zhong
Guobin Tian
Hualan Chen
Jianzhong Shi
Jiasheng Song
Kyoko Shinya
Shufang Fan
Tiegang Tong
Xiao-Ning Xu
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1000409
P407
P577
2009-05-01T00:00:00Z